Intervacc AB Sustainability Reports
Intervacc AB is a biotechnology company that develops and sells subcomponent vaccines against economically important bacterial infections within animal health. Its proprietary technology platform uses recombinant proteins to create targeted, safe vaccines such as Strangvac.
Sector: Manufacturing
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 549300OICIVZBBZRNZ64
FIGI: BBG0068DM0Z6
11 reports from 2014 to 2025
